Osaic Holdings
NRXP icon

Osaic Holdings’s NRX Pharmaceuticals NRXP Stock Holding History

Osaic Holdings’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.45K Buy
600
+510
+567% +$1.69K ﹤0.01% 7215
2026
Q1 		$191 Hold
90
– – ﹤0.01% 7568
2025
Q4 		$243 Sell
90
-1,000
-92% -$2.68K ﹤0.01% 7557
2025
Q3 		$2.53K Buy
1,090
+1,000
+1,111% +$2.86K ﹤0.01% 7064
2025
Q2 		$293 Hold
90
– – ﹤0.01% 7454
2025
Q1 		$184 Hold
90
– – ﹤0.01% 7175
2024
Q4 		$198 Buy
+90
New +$121 ﹤0.01% 7166
2024
Q2 		– Sell
-100
Closed -$472 – 7547
2024
Q1 		$472 Hold
100
– – ﹤0.01% 6835
2023
Q4 		$460 Sell
100
-1,013
-91% -$3.35K ﹤0.01% 6905
2023
Q3 		$2.89K Sell
1,113
-1,502
-57% -$5K ﹤0.01% 6487
2023
Q2 		$12.6K Sell
2,615
-108
-4% -$649 ﹤0.01% 5842
2023
Q1 		$17.9K Hold
2,723
– – ﹤0.01% 5629
2022
Q4 		$30K Buy
2,723
+667
+32% +$6.72K ﹤0.01% 5291
2022
Q3 		$15K Buy
2,056
+225
+12% +$1.52K ﹤0.01% 5794
2022
Q2 		$11K Buy
1,831
+913
+99% +$12K ﹤0.01% 6025
2022
Q1 		$22K Sell
918
-3,566
-80% -$116K ﹤0.01% 5631
2021
Q4 		$214K Buy
4,484
+195
+5% +$14.1K ﹤0.01% 3876
2021
Q3 		$398K Buy
4,289
+3,958
+1,196% +$515K ﹤0.01% 3271
2021
Q2 		$38K Buy
331
+296
+846% +$78.1K ﹤0.01% 5244
2021
Q1 		$12K Sell
35
-15
-30% -$5.43K ﹤0.01% 5780
2020
Q4 		$12K Buy
+50
New +$8.21K ﹤0.01% 5436

Other funds holding NRXP

BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Osaic Holdings's NRXP Position: Q2 2026 in Review

Osaic Holdings increased its NRX Pharmaceuticals (NRXP) stake by 567% in Q2 2026, buying an estimated $1.69K and bringing the position to 600 shares worth $2.45K. The position accounts for ﹤0.01% of the portfolio, ranked #7215.

Osaic Holdings first reported a position in NRXP in Q4 2020 and has held it in 21 quarters since. The position peaked at $398K in Q3 2021. 46 funds tracked by Wall St. Rank hold NRXP as of Q2 2026.

  • Osaic Holdings held 600 shares of NRX Pharmaceuticals worth $2.45K as of Q2 2026.
  • Osaic Holdings bought 510 NRX Pharmaceuticals shares in Q2 2026, an estimated $1.69K.
  • NRX Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7215 holding.
  • Osaic Holdings first reported a position in NRX Pharmaceuticals in Q4 2020 and has held it in 21 quarters since.
  • Osaic Holdings's NRX Pharmaceuticals position peaked at $398K in Q3 2021.
  • 46 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.